Submissions

Online Submissions

Already have a Username/Password for Indonesian Journal of Cancer Chemoprevention?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

 

Author Guidelines

1.    GENERAL TERMS

All submitted manuscripts must not be previously published and not under consideration for publication elsewhere. Papers may come from any country but must be written in English. The manuscript may be submitted as a review article or a research article.  There are no submission and processing charges for this journal.

All manuscripts are subjected to peer review. The manuscript must be accompanied by a covering letter signed by all authors. Upon acceptance, authors are allowed to hold the copyright without any restriction. It is the authors' responsibility to obtain permission to reproduce illustrations, tables, etc. from other publication.

 

2.    HOW TO SUBMIT

Authors are required to submit manuscripts electronically by using online journal system http://ijcc.chemoprev.org.

 

3.    REQUIREMENTS OF EACH MANUSCRIPT TYPE

  • Research Article: Research Article should consist of no more than 3,500 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 40 references.
  • Review Article: Only for invited authors. Review Article should consist of no more than 10,000 words, not including the words in abstract, references, table, figure, and figure legend. The manuscript should have no more than six figures and/or tables in total and no more than 200 references.


4. MANUSCRIPT

The manuscript must be written in clear and concise English and should comprise of: (a) Title Page; (b) Abstract; (c) Keywords; (d) Introduction; (e) Materials and Methods; (f) Results; (g) Discussion; (h) Conclusion (i) Acknowledgement, if any; (j) References. The manuscript should be typed in Times New Roman 12 pts with double space. 

Title Page
Title must be concise and informative. Authors' name and institution should be written accordingly.

First Author1,*, Second Author2, ..... (given name followed by surname)
1Institutional affiliation, city, country
2Institutional affiliation, city, country 

*Corresponding author: email address

Abstract and Keywords
The abstract provides a clear and concise summary of the article. The abstract should include a background for the work, a brief description of the methods, a summary of the results, and a conclusion. They are indicative only and will not be used for citation purposes. The abstract should be no more than 300 words (for Review Article) or 250 words (for Research Article). The abstract should be written in single space, 1 column. Keywords should be provided no more than 5 words and separated by commas (,).

Introduction
The introduction should be written in double space with 1 column format. The introduction should state the purpose of the study.

Material and Methods
The introduction should be written in double space with 1 column format. Materials and Methods should be described in detail sufficient to enable the work to be repeated, and suppliers of materials and equipment given, if necessary.

Results
The introduction should be written in double space with 1 column format. Results should be presented in logical sequence, with tables and figures as appropriate.

Discussion
The introduction should be written in double space with 1 column format. Discussion should emphasize the implication of the findings, limitations, and relevance to other studies. It should not be a recapitulation of the results.

Conclusion
Conclusion should state the significance of the study and its potential impact in the field. Conclusion has to be supported by results.

Acknowledgment
The acknowledgment should be filled with other contributors those are not qualified in the author's list. Research grant that supported the study should be listed in this section as well.

References
The Harvard System is used. References in the text should be quoted in the following for single, two or more than two authors respectively: King (2000), Hanahan and Weinberg (1999), Choi, et al. (2005). The references should be listed alphabetically at the end of the paper. The journal titles should be abbreviated to conform to the style of Index Medicus. The layout should be as follows.

for journal
Chen, Y., Shen, S. and Lin, H., 2003, Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids, Biochem. Pharmacol., 66(5), 1139–1150.

for book
Bruton, L., Lazo, J.S. and Parker, K.L., 2005, Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed, Lange: McGrawHill.

for chapter in book
Smith, J., 1975, A source of information. In: W. Jones, ed., 2000, One hundred and one ways to find information about health, Oxford: Oxford University Press. pp. 44-68.

for essay/thesis/dissertation
Wahyuningsih, M.S.H., 2006, Selektivitas dan Mekanisme Antikanker 5a-oleandrin dandehidrodeasetil-5a-oleandrin Hasil Isolasi daun jure (Nerium indicum Mill.), Dissertation, Universitas Gadjah Mada, Yogyakarta.

for proceeding
Adina, A.B., Handoko, F.F., Setyarini, I.I., Septisetyani, E.P., Riyanto, S. and Meiyanto, E., 2008, Ethanolic extract Citrus aurantifolia increase sensitivity MCF7 cell line towards Doxorubicin, Proceeding, Yogyakarta: Kongres Ilmiah ISFI ke-16, ISBN:978-979-95107-6-2, pp. 55-629.

for official document
Division of Drugs & Toxicology, 1994, Drug Evaluation Annual, New York: American Medical Association.

for website
Kementerian Kesehatan RI, 2015, Stop Kanker, Infodatin, Pusat Data dan Informasi, Website, http://www.depkes.go.id/resources/download/pusdatin/infodatin/infodatin-kanker.pdf, accessed on May 25, 2015.

Table and Figure
A detailed legend should be provided for each table and figure.

 

5. UNIT OF MEASUREMENT

  • Authors can express all measurements in Conventional or International System (SI) units.
  • Drug names must use generic names. When proprietary brands are used in research, include the brand name, the name and location (city & country) of the manufacturer in parentheses after the first mention of the generic name.


6. MANUSCRIPT TEMPLATE

You can use templates below for submitting manuscript.

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  2. The submission file is in OpenOffice, Microsoft Word, RTF, or WordPerfect document file format.
  3. Where available, URLs for the references have been provided.
  4. The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  5. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  6. If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
 

Copyright Notice

For the submission of a manuscript to Indonesian Journal of Cancer Chemoprevention, I hereby certify that:

1.  I have been granted authorization by my co-author/s to enter into these arrangements.

2.  I hereby declare, on behalf of myself and my co-author/s, that:
  • The manuscript submitted is an original work and has neither been published in any other peer-reviewed journal nor is under consideration for publication by any other journal. More so, the work has been carried out in the author/s’ lab and the manuscript does not contravene any existing copyright or any other third party rights.
  • I am/we are the sole author/s of the manuscript and maintain the authority to enter into this agreement and the granting of rights to the publisher: Indonesian Society for Cancer Chemoprevention (ISCC), does not infringe any clause of this agreement.
  • The manuscript contains no such material that may be unlawful, defamatory, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the agreement.
  • I/we have taken due care that the scientific knowledge and all other statements contained in the manuscript conform to true facts and authentic formulae and will not, if followed precisely, be detrimental to the user.
  • I/we permit the adaptation, preparation of derivative works, oral presentation or distribution, along with the commercial application of the work.
  • No responsibility is assumed by Indonesian Journal of Cancer Chemoprevention (IJCC) and ISCC, its staff or members of the editorial boards for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in a publication by IJCC.


Copyright:

Authors are allowed to keep the copyright without any restriction. Submission of a manuscript to the respective journals implies that all author/s have read and agreed to the content of the Covering Letter or the Terms and Conditions.  It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the manuscript for publication the author/s agree that the publishers have the legal right to take appropriate action against the author/s, if plagiarism or fabricated information is discovered. Once submitted to the journal, the author/s will not withdraw their manuscript at any stage prior to publication. 

 

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.